Cargando…
Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries
Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-...
Autores principales: | Moran, Andrew E., Farrell, Margaret, Cazabon, Danielle, Sahoo, Swagata Kumar, Mugrditchian, Doris, Pidugu, Anirudh, Chivardi, Carlos, Walbaum, Magdalena, Alemayehu, Senait, Isaranuwatchai, Wanrudee, Ankurawaranon, Chaisiri, Choudhury, Sohel R., Pickersgill, Sarah J., Watkins, David A., Husain, Muhammad Jami, Rao, Krishna D., Matsushita, Kunihiro, Marklund, Matti, Hutchinson, Brian, Nugent, Rachel, Kostova, Deliana, Garg, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440739/ https://www.ncbi.nlm.nih.gov/pubmed/36071923 http://dx.doi.org/10.26633/RPSP.2022.140 |
Ejemplares similares
-
Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective
por: Nugent, Rachel A., et al.
Publicado: (2020) -
Correction: Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective
por: Nugent, Rachel A., et al.
Publicado: (2020) -
The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020) -
The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review
por: Husain, Muhammad Jami, et al.
Publicado: (2022) -
Cost analysis of the WHO-HEARTS program for hypertension control and CVD prevention in primary health facilities in Ethiopia
por: Beshah, Senait Alemayehu, et al.
Publicado: (2023)